Company Filing History:
2 out of 155 
1 out of 4 
1 out of 23 Years Active: 2012-2017
Title: Innovations by Hyun Tak Jin in HPV Research
Introduction
Hyun Tak Jin is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of medical research, particularly in the development of treatments for cervical cancer. With a total of two patents to his name, his work focuses on innovative approaches to combat diseases caused by human papilloma virus (HPV).
Latest Patents
Hyun Tak Jin's latest patents include compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer. The inventions relate to a fusion protein that includes a fusion polypeptide of E6 and E7 of HPV, a signal peptide for secreting the polypeptide out of the cell, and an immune enhancing peptide for a subject. Additionally, the patents cover a polynucleotide encoding the fusion protein and a vector containing the polynucleotide. Furthermore, the inventions describe a pharmaceutical composition comprising the fusion protein or the vector, along with a method for treating diseases caused by HPV using the pharmaceutical composition.
Career Highlights
Throughout his career, Hyun Tak Jin has worked with reputable organizations, including the Postech Foundation and Genexine Co., Ltd. His experience in these companies has allowed him to advance his research and contribute to significant innovations in the medical field.
Collaborations
Hyun Tak Jin has collaborated with notable colleagues such as Young Chul Sung and Sang Hwan Seo. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.
Conclusion
Hyun Tak Jin's work in the field of HPV research exemplifies the importance of innovation in medical science. His patents and collaborations highlight his commitment to developing effective treatments for cervical cancer. His contributions continue to pave the way for advancements in healthcare.